Corcept Therapeutics, Inc. (CORT)
34.73
-0.66
(-1.86%)
USD |
NASDAQ |
Jan 16, 16:00
34.77
+0.04
(+0.12%)
After-Hours: 20:00
Corcept Therapeutics Market Cap: 3.653B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Axsome Therapeutics, Inc. | 8.937B |
| Johnson & Johnson | 526.82B |
| United Therapeutics Corp. | 20.02B |
| Ultragenyx Pharmaceutical, Inc. | 2.170B |
| Amicus Therapeutics, Inc. | 4.421B |
Market Cap Related Metrics
| PE Ratio | 39.68 |
| PS Ratio | 5.602 |
| Price to Book Value | 5.781 |
| Price to Free Cash Flow | 25.54 |
| Price | 34.73 |
| Earnings Yield | 2.52% |
| Operating PE Ratio | 63.32 |
| Normalized PE Ratio | 39.68 |